Chronic HCV Infection and Cerebrovascular Disease Risk
Researchers found data that showed chronic hepatitis C virus infection and associated carotid intima-media thickness and plaque are predictors for cerebrovascular disease.
All articles by Virginia Schad, PharmD
HBV Infection Associated With Nonliver Cancer, Particularly Digestive System Cancers
In China, researchers found data that showed that patients with HBsAg seropositive test results were at an increased risk of developing hepatocellular carcinoma, stomach cancer, oral cancer, colorectal cancer, pancreatic cancer, and lymphoma.
Glecaprevir/Pibrentasvir Is Efficacious for Treatment of HCV in Highly Endemic Areas
Researchers found data from that showed the once-daily, direct-acting antiviral regimen, glecaprevir co-formulated with pibrentasvir, is effective and safe in hepatitis C.
Gaps in Viral Hepatitis Awareness in the United States
US researchers found data that showed participants had a 32% of awareness for hepatitis B infection and 49% were aware of infection with hepatitis C virus.
HBV Vaccine Response In Adults With HIV and Coinfection Prevention
In Brazil, investigators found that approximately 80% of participants with HIV responded to the hepatitis B virus vaccine, which they believe correlates with a better prognosis and cost effectiveness for treatment.
Scaling-Up Prevention and Treatment Interventions for Achieving HCV Elimination
Researchers found data that showed that in order to eliminate the US health threat of hepatitis C virus within approximately 15 years will require both scaling up medication-assisted treatment and syringe service programs.
HDV Persists During Liver Regeneration and is Amplified Through Cell Division
Researchers found that hepatitis delta virus endures cell division in vitro and in vivo, which they believe shows a need for the development of antiviral agents that target hepatitis delta virus and reinfection of human hepatocytes.
An Optimized Cell Culture System Needed for Hepatitis E Virus Subtypes
After expanding, freezing, thawing and re-culturing novel wild-type isolates of hepatitis E, investigators in Europe observed what they categorized as an unlimited production of hepatitis E virus during a period of 2 years, which they believe will allow in vitro testing for the effectiveness of sofosbuvir in combination with ribavirin or silvestrol.
HEV Infections Among HIV-Positive Individuals During an Outbreak of Hepatitis A
Researchers found data that showed among patients who are HIV positive, hepatitis E viral transmission is unrelated to sexually transmitted disease.
Hepatitis B Virus Reactivation Following Rituximab Treatment in Rheumatoid Arthritis
Researchers found data that showed rituximab therapy for rheumatoid arthritis can induce hepatitis B virus in the early phase for patients who have positive test results for the hepatitis b surface antigen and in the late phase for patients with resolved hepatitis B virus infection.
Next post in Hepatitis Advisor
